Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study

BACKGROUND: Vaccination is an efficient strategy to control the COVID-19 pandemic. In north Cyprus, vaccine distribution started with CoronaVac followed by BNT162b2, and ChAdOx1 vaccines. An option to obtain a third booster dose with BNT162b2 or CoronaVac was later offered to people fully inoculated...

Descripción completa

Detalles Bibliográficos
Autores principales: Barin, Burc, Kasap, Ulus, Selçuk, Ferda, Volkan, Ender, Uluçkan, Özge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828370/
https://www.ncbi.nlm.nih.gov/pubmed/35165669
http://dx.doi.org/10.1016/S2666-5247(21)00305-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828370/
https://www.ncbi.nlm.nih.gov/pubmed/35165669
http://dx.doi.org/10.1016/S2666-5247(21)00305-0

Ejemplares similares